Psychometric validation of the Functional Assessment of Cancer Therapy-Endometrial among endometrial cancer patients.
Autorzy:
Kim S; Center for Clinical Epidemiology, Samsung Medical Center, Seoul, Korea.; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea. NohJJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Kim Y; Center for Clinical Epidemiology, Samsung Medical Center, Seoul, Korea. Cho J; Center for Clinical Epidemiology, Samsung Medical Center, Seoul, Korea.; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea. Kang D; Center for Clinical Epidemiology, Samsung Medical Center, Seoul, Korea.; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea. Lee YY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7096.
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
Autorzy:
Shim SH; Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea. Lee JY; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea. Lee YY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Park JY; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. Lee YJ; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea. Kim SI; Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea. Han GH; Department of Obstetrics and Gynecology, Inje University Sanggye Paik Hospital, Seoul, Korea. Yang EJ; Department of Obstetrics and Gynecology, Research Institute of Medical Science, Soonchunhyang University Cheonan Hospital, Cheonan, Korea. NohJJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Yim GW; Department of Obstetrics and Gynecology, Dongguk University College of Medicine, Goyang, Korea. Son JH; Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. Kim NK; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea. Kim TH; Department of Obstetrics and Gynecology, Konyang University Hospital, Daejeon, Korea. Kong TW; Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. Choi YJ; Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Cho A; Department of Obstetrics and Gynecology, Medical School of Jeju National University, Jeju National University Hospital, Jeju, Korea. Lim H; Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea. Jang EB; Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea. Cho HW; Department of Obstetrics and Gynecology, Guro Hospital, Korea University College of Medicine, Seoul, Korea. Suh DH; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea. .
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2024 Mar; Vol. 35 (2), pp. e66. Date of Electronic Publication: 2024 Jan 25.
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement.
Autorzy:
Kim JH; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. Kim DY; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. . Kim J; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. NohJJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hwang WY; Department of Obstetrics and Gynecology, School of Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Korea. Baek MH; Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea. Choi MC; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, College of Medicine, CHA University, Seongnam, Korea. Joo WD; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, College of Medicine, CHA University, Seongnam, Korea. Lee YJ; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea. Suh DH; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea. Kim YB; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2024 Mar; Vol. 35 (2), pp. e45. Date of Electronic Publication: 2024 Jan 05.
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer.
Autorzy:
Chang CS; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Ryu JY; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Choi JK; Department of Obstetrics and Gynecology, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu, Korea. Cho YJ; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Choi JJ; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hwang JR; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Choi JY; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. NohJJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Lee CM; Department of Immunology, School of Medicine, Konkuk University, Chungju, Korea. Won JE; Department of Immunology, School of Medicine, Konkuk University, Chungju, Korea. Han HD; Innovative Discovery Center, Prestige Biopharma Korea, Busan, Korea. Lee JW; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2023 Sep; Vol. 34 (5), pp. e58. Date of Electronic Publication: 2023 Apr 24.
Does Robot Assisted Laparoscopy (RAL) Have an Advantage in Preservation of Ovarian Reserve in Endometriosis Surgery? Comparison of Single-Port Access (SPA) RAL and SPA Laparoscopy.
Autorzy:
Kang JH; Department of Obstetrics and Gynecology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu-si 11759, Gyeonggi-do, Republic of Korea. Chang CS; Department of Obstetrics and Gynecology, Chung-Ang University Gwang-Myung Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si 14353, Gyeonggi-do, Republic of Korea. NohJJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea. Kim TJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Jul 14; Vol. 12 (14). Date of Electronic Publication: 2023 Jul 14.
The effect of adding chewing gum to oral carbohydrates on preoperative anxiety scores in women undergoing gynecological surgery: A randomized controlled study.
Autorzy:
Bang YJ; Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Lee JH; Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Kim CS; Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Choi DC; Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. NohJJ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Lee YY; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Min JJ; Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 25; Vol. 18 (4), pp. e0283780. Date of Electronic Publication: 2023 Apr 25 (Print Publication: 2023).
Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers.
Autorzy:
NohJJ; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Kim MK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea. Choi MC; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea. Lee JW; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Park H; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea. Jung SG; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea. Joo WD; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea. Song SH; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea. Lee C; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Oct; Vol. 54 (4), pp. 1200-1208. Date of Electronic Publication: 2021 Dec 13.
Where is ERAS in the management of advanced ovarian cancer?: between myths and truths.
Autorzy:
NohJJ; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Lee YY; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. .
Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers.
Autorzy:
Kim BW; Department of Information and Communication Engineering, Changwon National University, Changwon 51140, Korea. Choi MC; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam 13497, Gyeonggido, Korea. Kim MK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Korea. Lee JW; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Kim MT; Department of Information and Communication Engineering, Changwon National University, Changwon 51140, Korea. NohJJ; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Park H; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam 13497, Gyeonggido, Korea. Jung SG; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam 13497, Gyeonggido, Korea. Joo WD; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam 13497, Gyeonggido, Korea. Song SH; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam 13497, Gyeonggido, Korea. Lee C; Comprehensive Gynecologic Cancer Center, CHA Bundang Medical Center, CHA University, Seongnam 13497, Gyeonggido, Korea.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Nov 12; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 12.
Report from the 36th Annual Meeting of the Korean Society of Gynecologic Oncology (KSGO).
Autorzy:
Kim JH; Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea. NohJJ; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Eoh KJ; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Yongin Severance Hospital, Yongin, Korea. Kim YT; Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea. .
Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer: Analysis by Radiation Phase and Histologic Type.
Autorzy:
Kang JH; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Cho WK; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Yeo HJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Jeong SY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. NohJJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Shim JI; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Lee YY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Kim TJ; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Lee JW; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Kim BG; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Bae DS; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Park W; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Choi CH; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Oct 28; Vol. 9 (11). Date of Electronic Publication: 2020 Oct 28.
Anti-Cancer Activity of As 4 O 6 and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer.
Autorzy:
NohJJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Kim MS; Department of Obstetrics and Gynecology, St. Vincent's Hospital, Catholic University of Korea, Seoul 16247, Korea. Cho YJ; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Jeong SY; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Lee YY; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Ryu JY; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Choi JJ; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Bae I; Chemas Co., Ltd., Seoul 06163, Korea. Wu Z; Chemas Co., Ltd., Seoul 06163, Korea. Kim BG; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Hwang JR; Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Lee JW; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2020 Oct 19; Vol. 12 (10). Date of Electronic Publication: 2020 Oct 19.
Incisional hernia after 2498 single-port access (SPA) gynecologic surgery over a 10-year period.
Autorzy:
NohJJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul, South Korea. Kim TH; Department of Obstetrics and Gynecology, Konyang University Hospital, Konyang University School of Medicine, Taejon, South Korea. Kim CJ; Department of Obstetrics and Gynecology, Konyang University Hospital, Konyang University School of Medicine, Taejon, South Korea. Kim TJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul, South Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Oct 15; Vol. 10 (1), pp. 17388. Date of Electronic Publication: 2020 Oct 15.
The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer.
Autorzy:
NohJJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul 06351, Korea. Lim MC; Division of Tumor Immunology, Center for Gynecologic Center, and Center for Clinical Trials, Research Institute and Hospital and Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea. Kim MH; Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Korea. Kim YH; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea. Song ES; Medical Treatment Division, Gwangjin-gu Health Center, Seoul 05026, Korea. Seong SJ; Department of Obstetrics & Gynecology, CHA Gangnam Medical Center, CHA University, Seoul 06135, Korea. Suh DH; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, Korea. Lee JM; Department of Obstetrics and Gynecology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Korea. Lee C; Department of Obstetrics and Gynecology, CHA Ilsan Medical Center, CHA University, Seoul 10414, Korea. Choi CH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul 06351, Korea.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
